"This is the first time the department has sanctioned a health plan in recent history. The amount is significant," said Sarah Brooks, deputy director of health care delivery systems at the Department of Health Care Services.
California officials have fined health care giant Kaiser Permanente $2.5 million for failing to turn over required data on patient care to the state's Medicaid program.
The California Department of Health Care Services said this was the first fine imposed against one of its Medicaid managed care plans since at least 2000. The state relies on the data to help set rates, ensure adequate care is available and monitor how taxpayer dollars are being spent in the program, known as Medi-Cal in California.
Jennifer Kent, the department's director, notified Kaiser of the sanctions in a Jan. 13 letter that was obtained by California Healthline. The department later posted it online.
"This is the first time the department has sanctioned a health plan in recent history. The amount is significant," said Sarah Brooks, deputy director of health care delivery systems at the Department of Health Care Services. "We do take it very seriously."
Kaiser isn't appealing the sanctions and the health plan said it's "working toward compliance." The company said the sanctions were in no way related to the quality of patient care or access to treatment. (Kaiser Health News, which produces California Healthline, is not affiliated with Kaiser Permanente.)
Brooks said her agency is in ongoing discussions with Kaiser and additional fines could be imposed depending on the company's actions and whether Kaiser's violations put the agency out of compliance with federal rules. That could force the state to repay money to the Centers for Medicare & Medicaid Services, which funds the Medi-Cal program jointly with the state.
Kaiser, the state's dominant HMO, is among 22 health plans that participate in the Medi-Cal managed care program, which covers about 80 percent of Medi-Cal enrollees in the state.
The Oakland-based company failed to submit data on out-of-network care that Medi-Cal patients received from November 2014 to September 2016, according to the state. Kaiser also didn't file data on "all physician-administered drugs" from March 2010 to March 2015, records show. That information is about infusions and other drugs given to patients in a doctor's office or clinic.
The insurer missed a June 30 deadline to comply and a subsequent one Jan. 1, which triggered the current penalties. The fine related to medical claims was $742,500 and the drug data fine was $1.79 million, for a total of $2.5 million.
The reporting lapses are unusual since Kaiser pioneered use of electronic medical records and health data collection. But the company indicated in a statement that being an integrated health system that operates a health plan, its own hospitals and medical groups complicated matters.
Nathaniel Oubre, Kaiser Permanente's vice president for Medi-Cal, said its systems and technology — including electronic health records — are focused on "quality, access and integration of care."
But he said the systems were not designed or updated to collect information in the format required by the state.
"We are taking steps to change this," he said. "We are making investments in technology that will facilitate compliance with the state's data reporting requirements."
Medi-Cal represents a small portion of Kaiser's overall business, and some industry experts said the company may have been hesitant to alter its information technology systems to meet the state's demands.
Kaiser said it serves about 700,000 Medi-Cal enrollees across the state. Rival Anthem Inc. serves more than 1 million Medi-Cal patients.
In Medi-Cal managed care, the state pays insurers a fixed amount per enrollee to provide comprehensive care. That's different from the conventional fee-for-service system in which the state pays medical providers directly for services rendered.
In addition to being an insurer, Kaiser runs 38 hospitals across the country and hundreds of clinics. More than 18,000 salaried doctors work at its affiliated medical groups. Kaiser operates in eight states and the District of Columbia, but nearly 80 percent of its 10.6 million members are in California. For 2015, the company reported revenue of $60.7 billion and net income of $1.9 billion.
Kaiser has faced other stiff fines from California regulators. In 2013, the California Department of Managed Health Care fined the insurer $4 million for problems related to mental health treatment.
Two years later, the managed care agency criticized Kaiser again for failing to address the long delays in treatment for mental health patients.
Brooks said the state is rolling out a new ratings system for all Medi-Cal managed care plans next year that will track the quality of patient care, appeals processes, contract compliance and other performance measures.
Governor Jerry Brown said his state would not "turn back" on advances it's made in health coverage. Under the new federal leadership, he said, the "future is uncertain and dangers abound."
In an unusually impassioned speech, Gov. Jerry Brown vowed Tuesday to protect California's health care gains under Obamacare against Republican attempts in Washington, D.C., to roll them back.
"More than any other state, California has embraced the Affordable Care Act," Brown told state legislators and appointees in his annual State of the State address at California's Capitol. "I intend to join with other Governors and Senators, and with you, to do everything we can to protect the health care of our people."
Brown said California would not "turn back" on advances it's made in health coverage under pressure from the new Republican administration in Washington. Under the new federal leadership, he said, the "future is uncertain and dangers abound."
Health coverage for Californians under the Affordable Care Act "has come with tens of billions of dollars from the federal government," said Brown. "Were any of that were to be taken away, our state budget would be directly affected, possibly even devastated."
Leveraging an estimated nearly $20 billion federal money, health coverage has been extended to five million Californians under Obamacare, which includes federally subsidized private health plans and an expansion of eligibility for Medicaid, the program for low-income people — known in this state as Medi-Cal.
Brown received cheers and several standing ovations from legislators during his speech, an address intended to set the state' policy-making tone for the year. The 78-year old governor was visibly energized during his 16-minute speech, often speaking in an emphatic, defiant tone. While also emphasizing renewable energy initiatives and an inclusive immigration policy, Brown veered off script to voice support for women's reproductive health care.
"We're going to fight for Planned Parenthood, which has been unfairly attacked in too many places in this country," he said.
Health care advocates quickly piped up on Twitter and in press releases to support the governor, saying he is rightly alarmed at the threat of losing billions of federal dollars not just from the repeal of the Affordable Care Act, but also under Congressional proposals to change Medicaid into a state block grant program.
"We look forward to working with [Governor Brown] to fight for our health in Congress," Anthony Wright, executive director of Health Access, said in a statement.
Kieryn Darkwater, a young transgender person of color, praised the speech on Twitter, saying it provided reassurance that California is a safe place for immigrants and others who are "marginalized."
"I deeply appreciated that he spent so much time talking about the issues of health care and protections for our communities," Darkwater, an Oakland-based activist, artist and programmer said via email to California Healthline.
Darkwater is enrolled in Medi-Cal, which covers much-needed mental health medications and gender transition hormone treatments.
"Medi-Cal is currently keeping me both alive and able to stay afloat financially," Darkwater said.
Assemblymember Rob Bonta, D-Oakland, the former chairman of the Assembly Health Committee, tweeted that he was proud Brown "came out swinging in strong defense of health, immigrants, [and] science."
Even some state Republicans responded favorably to Brown's call for bipartisanship.
Senate Republican Leader Jean Fuller, R-Bakersfield, said reaching across party lines is especially important to build bridges with national policymakers.
"Working with Washington should emulate the bipartisan successes we have had in our state," Fuller wrote in a statement.
Covered California, the state's Obamacare insurance exchange, reported strong enrollment numbers today despite uncertainty surrounding a possible repeal of the health reform law. Officials said 320,000 Californians have signed up in the subsidized marketplace since November, roughly on par with last year's enrollment over the same time period.
President Donald Trump's executive order on Inauguration Day did not provide administration officials with any new powers to unravel parts of the Affordable Care Act.
The Trump administration has significant power to undermine the workings of the Affordable Care Act. The bigger question is how much of that power it will use.
President Donald Trump's executive order on Inauguration Day urging federal officials to "take all actions consistent with law to minimize the unwarranted economic and regulatory burdens" of the federal health law did not provide administration officials with any new powers to unravel parts of the law.
"They had all this authority before," said Len Nichols, a health policy professor at George Mason University in Virginia who supports the health law. Trump, he said, "is signaling 'I care' " about this issue.
In the short term, efforts will be minimal, said Joe Antos of the conservative American Enterprise Institute, because the White House is still getting its personnel on board. There are no high-level political appointees yet installed at the Department of Health and Human Services, Labor and Treasury, which have primary authority over the law.
"They need their appointees," said Antos. Until more Trump personnel actually start work, he added, "I don't think they're going to be able to do much." The nominees for secretaries of HHS, Labor and Treasury are encountering various degrees of turbulence in their Senate confirmation process.
But even when the new personnel do take office, it remains unclear exactly how far the new administration will go. That's because while they can make the law stop working, it will take Congress to actually put in place something new.
"If they start down that road" of unraveling the law, said Nichols, "then the insurers will pull out as soon as possible. And 2018 will not be pretty." That's a reference to the fact that plans offering coverage in the individual market are concerned that changes would make it easier for healthy people to exit the market, leaving only sicker and more expensive people behind and no way to spread costs.
Yet both Trump and Republican leaders in Congress have vowed not to strip away anyone's insurance and to provide a "stable transition"to a new system. Trump told The Washington Post earlier in the month his goal was "insurance for everybody."
And Antos said that many of the administration's options might be more difficult than they first appear.
For example, he pointed to one item that has been widely speculated as a possible change the administration is considering: cutting back the specific requirements for benefits that have to be included in various health plans.
Although such alterations are theoretically subject to rewrite through regulations, "it's the state insurance commissioners that approve that," he said. "The states all changed their regulations in order to conform with the federal rules."
Indeed, according to the National Conference of State Legislatures, 46 states enacted more than 175 separate laws between 2011 and 2013 to bring their rules into accord with the federal health law.
Those states "might have to repeal or amend their laws if the ACA were repealed," said Timothy Jost, an emeritus law professor at Virginia's Washington and Lee University who has studied the health law extensively. "For example, states that adopted the insurance reforms into law might find their markets nonviable without the federal subsidies and mandates."
In addition, any changes made by the Trump administration would have to take care to stay within the confines of federal requirements, including allowing for public notice and comment, said Antos, which gets particularly complicated with health care because it crosses so many boundaries.
"There has to be coordination between HHS and Treasury and maybe Labor, and it has to be legal," he said. "So understanding what you can and cannot do is going to be very difficult."
To be clear, there are a couple of actions the administration could take fairly easily that would have a major impact. The largest would likely come from dropping the appeal of a lawsuit that would immediately end cost-sharing help for up to 6 million people with incomes under 250 percent of the poverty line.
That would almost certainly send the insurance market for individuals into chaos, both backers and opponents of the health law agree, and would interfere with GOP promises to try to ensure stability in the market until they can come up with a replacement.
A second, more strategic change would be to eliminate the special rule that ensures that members of Congress and their staffs can still get employer contributions for their insurance, even though the law requires them to purchase that coverage through the health law's insurance exchanges.
"If Trump undoes that, then members and staff take a pay cut of up to $12,000 immediately," because they would have to make up the premium costs on their own, said Michael Cannon of the libertarian Cato Institute, an opponent of the health law. "That will motivate members of both parties to behave differently" in the speed with which they might come up with a health law replacement.
But even Cannon, who would like to see the law eliminated as soon as possible, concedes that "the politics of those two things would be dicey."
This story has been updated to correct a reference to the Trump administration's decision on the appeal of a lawsuit over the health law. That suit deals with funding for cost-sharing help for low-income marketplace customers and does not affect premium subsidies.
Tom Price pressed Medicare officials on a funding change that led to a windfall for the small biotech company run by one of his top campaign contributors, according to a document released under an open records request.
Tom Price, the Georgia congressman tapped for the nation's top health job, pressed Medicare officials on a funding change that led to a windfall for the small biotech company run by one of his top campaign contributors, according to a document released under an open records request.
Price is facing a Senate hearing Tuesday on his nomination to be secretary of Health and Human Services, a role that would put him at the helm of an agency overseeing billions in spending. His initial hearing revealed the depth of Democratic lawmakers' concerns about Price's investments in health care stocks.
The document shows for the first time the nature of the assistance Price provided for MiMedx, a firm in his district that would become a top campaign contributor, seeding his political funds with more than $40,000 in the years since Price directed the letter to Medicare officials.
The Medicare letter that Price and seven other lawmakers sent on Oct. 9, 2013, was related to a product called EpiFix, a small graft made of pulverized placenta that's meant to aid wound healing. Price's signature is first on the letter, which was signed by five other physicians who are members of Congress.
"Senate Democrats may find it significant that MiMedx only began contributing to Rep. Price after he intervened with Medicare on their behalf," said Brett Kappel, a campaign finance lawyer in Washington. "He was the company's congressman for 10 years before that, and no one at the company had contributed to him before the Medicare decision in the company's favor."
Before President Donald Trump's swearing-in Friday, a spokesman for Trump's transition acknowledged that Price has helped the company "in navigating regulatory waters, just as he would for any constituent."
A request for comment Monday directed to the HHS press office was answered by a senior communications adviser at the agency who lauded Price as a physician who is "grateful for the opportunity to bring his expertise to enacting better policies."
"Any suggestion that his motivations for public service have been anything other than to seek to improve the lives of the American people is simply wrong," said Ryan Murphy, the HHS adviser, who was previously a spokesman for Price in his personal office and most recently communications director for the House Budget Committee, of which Price is chairman.
In an emailed response to questions, MiMedx chief executive Pete Petit said Monday that the company made a presentation to the Congressional Doctors Caucus in Washington in support of Medicare's proposed payment change, in line with the letter Price and others sent. Petit said they did so even though the proposed change was "worse for MiMedx," but "the best policy for the industry."
He acknowledged, though, that the policy Medicare ultimately approved was "a win for MiMedx and the industry because the final rule amount reimbursement increased over the proposed rule amount."
The company makes skin grafts and injections made of placentas and amniotic membranes, which are meant to help with wound healing.
Federal campaign finance records show MiMedx, through its political action committee, chief executive and his relatives, has contributed more than $40,000 to Price's campaign and joint fundraising committees since 2014, with contributions starting six months after Price sent the letter. With combined PAC and individual donations, the company was ranked as Price's top contributor for 2015-2016 by the nonpartisan Center for Responsive Politics.
The 2013 letter to then-Medicare administrator Marilyn Tavenner has strong echoes of the same concerns MiMedx executives were airing at the time. It touches on the issue of "waste" in the use of oversized grafts used to help heal wounds around the ankle and on the feet of people with diabetes. The letter says $75 million in wound grafts were wasted in 2011 because of an inefficient pricing model that paid for sections of graft that were being thrown away. It encourages Medicare to move to a new, tiered system of reimbursing for the wound grafts.
"As stewards of our taxpaying constituents' dollars, we are committed to ensuring public programs such as Medicare are administered in the most efficient manner," Price and seven other congressmen wrote in the letter to Tavenner released under a records request by CQ HealthBeat. "We believe this proposal will reduce waste."
In an earnings call that same month, Petit reported that the company had been "quite busy in Washington meeting with Senators and Congressmen and encouraged them to support the CMS reimbursement change on skin substitutes."
Also that October, executives briefed investors on concerns that resemble those detailed in the lawmakers' letter. The earnings call transcript said competitors' grafts result in "massive wastage" that they estimate at $100 million, given that 80 percent of competitors' grafts are discarded.
It wasn't long, though, before MiMedx had great news. During a Dec. 5, 2013, call with investors, the company reported that Medicare changed its wound payment policies in ways that exceeded its expectations. The changes include ending the waste and moving to a tiered payment system.
Executive Bill Taylor estimated that doctors can pay the company $318 for a sheet of EpiFix and then bill Medicare for $1,371.19 in reimbursement. The result: Doctors who use EpiFix on patients would be able to keep about $1,000, a strong incentive to use the graft.
"It's a real win for MiMedx," Petit told investors.
The company has seen significant revenue growth, reporting in a press release that its income for 2014 — the year the Medicare pay change took effect — was $118 million, double the amount it earned the year before. Company executives have told investorsthe advanced wound care market is expected to be worth $1.25 billion in 2018.
Earlier this month, Kaiser Health News reported that Petit urged employees in 2015 to contribute to its PAC as he was publicly pressing the Food and Drug Administration to change its stance on the regulation of the injection.
An email from Petit's address sent to managers demanded donations "IMMEDIATELY" to the company's PAC, according to documents reviewed by KHN.
"I'm going to ask one more time for our field management to send something to our PAC. And, IMMEDIATELY," said the email sent under Petit's name. "We have PAC business to transact, and we need at least 50 donors to do so."
The ongoing FDA scrutiny could potentially affect the company's bottom line or lead to a recall of their injectable wound-care products, the firm told investors in 2013. The FDA declined to say whether it heard from Price about the company or to answer questions about its review of MiMedx products. Petit, a prominent businessman in the Atlanta suburbs, served as a Trump campaign finance chair in Georgia. Petit said he and his wife saw Price and his wife at an inaugural event but did not discuss MiMedx.
Research published in the Annals of Internal Medicine found that the number of chronically ill Americans with insurance increased by about 5 percentage points in 2014, the first year the law required Americans to have coverage.
As President Donald Trump and Republicans in Congress devise a plan to replace the 2010 health law, new research suggests a key component of the law helped people with chronic disease get access to health care — though, the paper notes, it still fell short in meeting their medical needs.
Research published Monday in the Annals of Internal Medicine found that the number of chronically ill Americans with insurance increased by about 5 percentage points — around 4 million people — in 2014, the first year the law required Americans to have coverage, set up marketplaces for people to buy coverage and allowed for states to expand eligibility for Medicaid, the federal-state insurance plan for low-income people. If states opted into the Medicaid expansion, people with chronic illnesses such as heart disease, diabetes, depression and asthma were more likely to see those gains.
Still, the study suggests, the law fell short in terms of guaranteeing those people could get medical treatment, see a doctor and afford medications.
The study is the first to examine how the health law affected people with these long-term diseases, which require careful and continuous management, and whose treatment drives a vast majority of the nation's health care costs. If these people don't get regular treatment they are especially likely to wind up needing emergency care.
"This hones in on the patients that are most dependent on having coverage and access," said Danny McCormick, an associate professor at Harvard Medical School and senior author on the study. "Most chronic conditions require ongoing treatment. And if you don't get it, often it results in more expensive care downstream."
As the GOP crafts its replacement plan, those findings could indicate what elements of the law are worth keeping, and what needs to be addressed. The Medicaid expansion in particular has come under heightened scrutiny from the GOP. This past weekend, a senior aide to President Donald Trump also said the administration wants to turn control of the program over to states, which experts say could result in less funding.
The researchers say their findings suggest reversing the Medicaid expansion would pose significant problems for people with long-term illness.
They used data from the Behavioral Risk Factor Surveillance System — an annual survey jointly run by state health departments and the Centers for Disease Control and Prevention — to examine records for more than 600,000 adults with at least one chronic condition. Diseases included coronary artery disease, stroke, asthma, pulmonary disease, diabetes, depression and arthritis. They compared insurance rates in the three years and examined whether people used that insurance to see a doctor.
"There's a clear difference between what happened for [chronically ill] individuals in states, based on how states implemented Medicaid. The Medicaid expansion was one of the strongest parts of the law," McCormick said.
If policymakers are serious about using health dollars more efficiently, and getting better health outcomes, he added, the findings support including such an expansion in any new policy platform.
The paper builds on research suggesting people generally were more likely to get insurance if they lived in states that expanded Medicaid. States such as West Virginia, Illinois and Kentucky — which opted into the expansion — saw double-digit gains in coverage of chronically ill people.
"Medicaid expansion is one of the tools you would think of to help people with chronic conditions – and we are seeing more evidence this is the case," said Benjamin Sommers, an associate professor of health policy and economics at Harvard's public health school, who was not involved with this study. "The question of whether this informs [the policy] debate — it clearly should. It clearly should be relevant."
That said, Obamacare was hardly a panacea, the researchers argue. Even after the law's insurance changes, about 15 percent of people with chronic disease didn't have coverage. More than one in four didn't have a check-up in 2014. About 23 percent of people with chronic disease still had to go without doctors' visits because of factors like cost. And those gaps were more pronounced for blacks and Hispanics. They were more likely on average to remain uninsured even after the health law took effect and to face obstacles in using new health insurance if they had it.
The paper suggests some possible causes: People didn't understand how to use their insurance, or they had plans that required them to pay out of pocket large copays or deductibles — flat spending fees consumers have to front before coverage kicks in. Many marketplace plans were categorized as "high-deductible plans."
"You've got hypertension or diabetes, and you have a very low income. It's really hard to take your medications" without coverage and minimal cost-sharing, McCormick said. "Someone who's insulin dependent who doesn't get insulin? it's going to result in an emergency room visit, or a hospital visit. There's a large potential for downstream complications."
But those gaps in coverage and access to care probably got smaller in the years following 2014, Sommers suggested. Other research has shown that with time, more people got insurance and learned how to use it.
"This is likely the tip of the iceberg in terms of what the Affordable Care Act was doing," Sommers said. "It's useful and part of a larger body of evidence making it clear access to care has improved among a range of populations."
But, he noted, the findings do emphasize an important issue: The health law by itself did not expand health care to all Americans, or even all Americans with chronic conditions.
"The Affordable Care Act is not a universal coverage law. It's a huge expansion for coverage but still left 20 to 30 million uninsured," he said. "Even for those with coverage, some are still experiencing challenges."
Trump has not yet offered his plan but said universal coverage will be part of his health care plan — although aides have since walked back on that claim. Meanwhile, an analysis this month by the nonpartisan Congressional Budget Office suggested that the repeal plan offered last year by Republicans eventually would increase the uninsured population by as many as 32 million.
Letters provided by CMS after an open records request show that the Health and Human Services pick has repeatedly stepped up in favor of drug firms, device manufacturers and higher physician payments.
As Cabinet nominee Tom Price faces a Senate confirmation hearing Tuesday, a newly released trove of documents sheds further light on how he interacted as a congressman with the Centers for Medicare and Medicaid, the massive agency he may soon oversee.
Letters provided by CMS after an open records request show that the Health and Human Services pick has repeatedly stepped up in favor of drug firms, device manufacturers and higher physician payments, leading some experts to question whether he would be a reliable advocate for the public's health.
The documents reveal additional instances where Price, a doctor from Georgia, set aside his priority of budget discipline in favor of special medical interests, including by sending a letter endorsing a medical procedure that Medicare later decided not to pay for, pointing to weak evidence that it helped patients get better.
"He's clearly shown in this case and in other ways allegiance to the corporate interest, but not to the patient interest," said Diana Zuckerman, president of the National Center for Health Research, a nonpartisan think tank that has studied medical device safety.
Price aligned with pharmaceutical firms in one letter, criticizing a policy meant to steer doctors away from the costliest drugs. He also sided with physicians who balked at a move to cut their pay for epidural pain relief injections.
A spokesman for the Trump transition, Phillip Blando, said Price has "always brought a compassion and commitment" to caring for patients and his public service as a lawmaker.
"Any suggestion that his motivations for public service have been anything other than seeking to improve the lives of the American people is simply wrong," Blando said in a statement.
On Wednesday, Democratic lawmakers pressed the Republican congressman on his investments and elicited few details on the congressman's plans for replacing Obamacare during a four-hour Senate health committee hearing.
Pointed questions came from Sen. Patty Murray, D-Washington, who grilled Price about his investment in an Australian drug company, Innate Immunotherapeutics. Price bought stock cheaper than what was offered on the open market, according to a Kaiser Health News report cited in the hearing.
Newly released documents show that in August, Price signed a letter to Medicare criticizing the use of "step therapy" in the drug program for seniors. The policy encourages doctors to first prescribe low-cost, established drugs and determine if they're working before going to newer, more expensive options. In the letter, Price and eight other lawmakers said the program should remain flexible enough that it does not "take prescribing power out of the hands of physicians."
Julie Donohue, co-director of the University of Pittsburgh Center for Pharmaceutical Policy and Prescribing, said Medicare's use of step therapy is one of the few tools it has to contain soaring drug costs.
"Unfortunately, unfettered choice of medicines … leads to higher drug spending and higher cost for taxpayers, so you have to strike the right balance," Donohue said.
Another letter in 2013 would have helped major pharmaceutical firms by reducing the reports they must file on educational materials they hand out to doctors. Price and 22 other lawmakers wanted to relieve the companies from reporting what they spend giving doctors journal article reprints or textbook chapters. At the time, Medicare declined to make a change.
Dr. Adriane Fugh-Berman, a physician and Georgetown University professor who studies drug industry relations with doctors, said the disclosure is important since such materials handed out to doctors are often vetted and controlled by drug companies, and then are used as promotional materials by sales teams.
A proposal similar to the 2013 letter recently emerged as a flashpoint before the 21st Century Cures Act passed in December. Then, Sen. Charles Grassley threatened to hold up the bill over a provision exempting drug firms from reporting on the handouts, as well as another stream of funding, continuing education to doctors.
"With taxpayers and patients paying billions of dollars for prescription drugs and medical devices, and prices exploding, disclosure of company payments to doctors makes more sense than ever," Grassley said in a November statement, spurring the provision to be dropped.
Another letter shows Price endorsing a medical procedure before it was proven to help patients.
In a 2012 letter, Price urged Medicare officials to assign a payment code for a new procedure meant to relieve a condition associated with lower back pain. Price's letter notes that the procedure was pioneered by a California company called Vertos Medical that sells the device used to perform the spinal operation.
"We have spoken with providers unaffiliated with Vertos who … have confirmed that this is a significant therapy that we need to advance," according to the letter signed by Price and Dr. Bill Cassidy, a Republican Louisiana senator who is also a physician.
Lobbying records show that Vertos spent $70,000 on lobbying in 2012, the same year Price and Cassidy sent the letter. Lobbying records do not show whether Vertos reached Price. Vertos and its lobbyist, Jeffrey J. Kimbell & Associates, did not respond to requests for comment.
The doctors' request to Medicare, though, did not achieve the desired outcome. Medicare officials later examined research saying the procedure had helped patients, but issued a decision refusing to pay for it, citing "weak studies, questions about missing information, questions about adverse events and conflicts of interest."
The Medicare decision says "the evidence does not support a conclusion of improved health outcomes for our Medicare beneficiaries."
In 2014, Medicare said it would pay for the procedure only if it's done as part of more rigorous studies, which so far have had favorable results.
Price waded in with the Congressional Doctors Caucus in early 2014 over another controversial medical procedure. He and seven other lawmakers signed a letter complaining about a Medicare pay cut to doctors who perform epidural pain-relief injections on patients' spines.
The letter also came after researchers began to question whether the side-effects of the spinal injections — including nerve damage, paralysis and strokes — were worth the short-term pain relief benefit, according to a report in the journal Surgical Neurology International.
Medicare responded to lawmakers' concerns over the proposed pay cut, saying it was the result of an analysis comparing doctor pay rates to the amount of time the services take to perform. Medicare ultimately reduced the scope of the pay cut, though, after heavy lobbying by pain physicians and lawmakers.
Murray and other Senate Democrats have called for a House ethics inquiry into Price. Public Citizen, a nonprofit government accountability group, also filed a complaint with the Securities and Exchange Commission.
"After this week's hearing, I'm afraid we have more questions than answers about Congressman Price's stock trades and the kind of information he had when they were made," Murray told reporters Thursday. "I remain deeply disappointed that Republicans brushed aside these serious concerns and decided to hold his nomination hearing anyway."
Lawmakers have recently called for an investigation into Price's purchase of six pharmaceutical company stocks in March, weeks before he led a bipartisan effort to quash a policy change that would have hurt the companies' bottom line. In last week's hearing, Price said his stockbroker made the purchases without his knowledge.
In Houston, tackling the problems of super-utilizers took unprecedented planning among typically disjointed city and county agencies, hospitals and nonprofits. Now, many hospitals and the fire department pool their data.
HOUSTON — Donning a protective gown, rubber gloves and a face mask, Dayna Gurley looks like she's heading into surgery. But Gurley is a medical social worker charged with figuring out why her client, a man who uses more health care services than almost anyone else in Houston, has been in three different hospitals in the last month.
The patient, who asked not to be identified, has chronic massive ulcers, AIDS and auditory hallucinations. He rents a cot in another person's home but is more often homeless, with no family to help him.
"It's almost like self-sabotage," Gurley said about her many attempts to steady her client's life. "We get really close to an important doctor's appointment or getting him connected with stable housing, and his impulsiveness gets in the way of that."
Patients like the Houston man are health care's so-called "super-utilizers"— people with complex problems who frequent emergency rooms for ailments more aptly handled by primary care doctors and social workers. They cost public and private insurers dearly — making up just five percent of the U.S. population, but accounting for 50 percent of health care spending.
As health care costs continue to rise, hospitals and doctors are trying to figure out how to find these patients and get to the root of their problems.
An effort to do just that started in New Jersey's poorest city, Camden, more than a decade ago. Inspired by the way police departments mapped crime data to detect "hot spots," family physician Dr. Jeffrey Brenner dug into ambulance records and emergency department data to show how high-cost patients were shuttling between city hospitals.
"In America, we're medicalizing social problems and we're criminalizing social problems, and we're wasting huge amounts of public resources," Brenner said. "We have the wrong tools to solve the wrong problem."
To steer patients away from expensive emergency care and push health systems to change the way they do business, the Affordable Care Act funds programs called Accountable Care Organizations. These are networks of hospitals, physicians and others who team up to improve care, lower costs and reap the savings.
Brenner's team at the Camden Coalition includes Latonya Oliver and Bill Nice, social workers who seek out patients like Peter Bowser in local neighborhoods. Bowser was once homeless and went to the emergency department nearly 30 times in one year.
But after Oliver and Nice helped get a permanent roof over his head, Bowser's trips to the ER all but stopped.
"I think you'd prefer to spend your time here than in the hospital any day of the week," Nice said to Bowser on a recent afternoon, gathered at the kitchen table in his tidy apartment.
This high touch, data-driven approach has yielded big savings. ER visits for the first group of patients dropped by 40 percent, cutting monthly hospital bills from $1.2 million dollars to $500,000.
Since then, Brenner has sought to spread the model around the country. One example is the Patient Care Intervention Center in Houston, a sprawling city desperate to aid its sickest and most isolated patients.
While the more than 100 hospitals here typically know their own super-utilizers, they had no way of knowing the top users across the entire city.
Tackling that problem took unprecedented planning among typically disjointed city and county agencies, hospitals and nonprofits. Now, many of the hospitals in Houston and the fire department pool their data and send it to Kallol Mahata, a former oil industry IT engineer with the patient care intervention center who combines it into one database.
Mahata and Dr. David Buck, the group's founder, help to identify patients at the top of the list—the outliers of the outliers.
Teams are dispatched to parks and neighborhoods to find the patients.
Firefighters and paramedics like Thomas Pierrel often know these residents from 911 calls. But this time, their mission is different: to encourage them to enroll in the volunteer program.
Inside one super-utilizer's threadbare home, Pierrel makes his pitch. "We go with you to your doctors, we make appointments, we find specialists. We try to maximize the resources that you have," he tells the prospective client.
The results of these intensive interventions can be stunning.
Timmy Williams was dying when Dayna Gurley found him.
He was holed up at home and reeling from untreated HIV that had progressed to AIDS. He couldn't take care of his young son and cycled through Houston's hospitals.
"When we first met Timmy, he was very hard to engage," Gurley recalled. "We knew that he probably was not taking any of his medication, and he was very skinny."
She arranged for a home aide to care for Williams seven days a week, got his apartment cleaned and the lights turned back on.
Now, Williams' HIV is undetectable and his health — and life — have been steadied.
In the two years since Houston's Patient Care Intervention Center has been up and running, costs for those in the program have gone down 83 percent and hospital visits by 70 percent.
But it can be difficult to keep these programs moving. Often insurance companies and government payers reap those savings, rather than hospitals. Buck and Dayna Gurley were once banned from a Houston hospital whose executives feared losing money if their high-cost patients stopped showing up.
"Nobody wants to take ownership of any of it," said Buck, his voice bristling with frustration. "The people just want ownership of what they have authority over, and that's really the issue: each of these areas are little fiefdoms."
Back in Camden, even Brenner is less optimistic than he once was. His office now overflows with pillows and kitchenware for clients the Camden Coalition is trying to place in housing. And he thinks homelessness and entrenched financial interests in health care are the biggest barriers.
"I think this is going to take a lot longer than I ever imagined," he said. "I think we're in a 20-year arc of recalibrating and rethinking what is health and what's health care? What's the purpose of our health care system? What are we trying to accomplish?"
But Brenner still believes these intensive efforts are the best way to help patients like Timmy Williams. He's now healthy enough to make his way around the city on his own, says Gurley, and her super-utilizer team did more than rescue him from his darkest days.
"I had to put it in my head that no one is going do it for me," he said. "I have to do it for myself. I have to step out and do it myself."
At home now with his son, his illness no longer gets in the way of being the father he wants to be.
But it's unclear how these efforts will be affected by a Trump administration, which along with congressional Republicans wants to repeal the health law.
This KHN story also ran on PBS NewsHour. PBS NewsHour producer Jason Kane contributed to this report.
Andy Slavitt, outgoing head of the agency that runs CMS, is making a name for himself with a barrage of fiery Tweets in defense of the Affordable Care Act.
Government bureaucrats are not often Twitter celebrities. But Andy Slavitt, current head of the agency that runs Medicare and Medicaid, is making a name for himself with a barrage of fiery Tweets in defense of the Affordable Care Act, breaking with the traditionally mute posture taken by federal employees.
As the Act — known as Obamacare — is coming under attack by the new Republican-controlled Congress and incoming Trump administration, Slavitt, acting administrator of the Centers for Medicare & Medicaid Services, isn't being shy online.
"Taking health care coverage away from people is easy. Creating coverage for people is hard. We did the hard," he tweeted on Dec. 15, and pinned to the top of his Twitter page.
Or this, on the day after Christmas: "A number of people tweeted me over the weekend that some people don't deserve health care but they apparently do. That's bull."
Slavitt, an infrequent Tweeter before the election, has sent out 3,200 Tweets since Dec. 6. He doesn't hide behind the usual "retweets are not endorsements," twitter bio, instead he now writes: "After Jan. 20, the mission is not over."
Slavitt acknowledges that his heightened enthusiasm for the medium has coincided with renewed interest in repealing the ACA, though he says he hasn't changed his tone, he's just getting more attention now. "The reason you're seeing a lot of things going viral is people are starting to realize what's at stake," he said in an interview.
He's openly mocked Republican efforts to replace the law, tweeting out a link to a cnbc.com story in January reporting that repeal would increase the federal deficit with a sarcastic caption:
Wait. Shouldn't changes make things better?
-Increasing the deficit
-And no $ for a replacement plan
He's been using his feed to solicit stories of Americans worried about losing their coverage. In one harrowing exchange in January, a woman from Arkansas tweeted at Slavitt, saying she would take her own life if she lost her insurance. "Hang in there please, there are many who will fight 4 your access 2 care. We will reach out to you directly. Copying CMS champ @AislingMCDL," he responded, referring to Aisling McDonough, the senior communications strategist for CMS.
While his approach often draws "sniggers from the communications team" at CMS, Slavitt said that, at the end of the day, his job is to communicate the needs of patients, and make the often robotic and inaccessible bureaucracy of the federal government into something more human and relatable.
"I leave my family every day during the week to come to Washington to do my job. The terms I agreed to were to speak my mind and do what I think is right," said Slavitt, who lives in Minnesota. "I'm not going to be right every time. If people want to criticize, I'm willing to take that."
Once he is replaced under the new administration, Slavitt wrote — in a Tweet — on Jan. 15:
More work to do after 1/29. I plan to keep working with all who are willing to make health care better.
The next day he went further: "Flying in for my final Monday @CMS.gov w plenty of work to do still. Considering chaining myself to my desk but my wife says bad idea."
Being more controversial or opinionated is often the only way to cut through the noise of Twitter, according to Cliff Lampe, an associate professor of information at the University of Michigan who does research on social media. "Making emotional responses, rather than neutral, or even controversial ones will get you more attention in the marketplace," he said.
Lampe predicted that more officials, not fewer, will start to take Slavitt's approach to gaining the public's attention. After all, it worked for President-elect Donald Trump.
Asked about comparisons to the incoming President, @realDonaldTrump, Slavitt's rapid response: "He has more followers than I do. I'm very jealous. I'd love to have 19 million."
Federal officials this month warned 21 Medicare Advantage insurers with high rates of errors in their online network directories that they could face heavy fines or have to stop enrolling people if the problems are not fixed by Feb. 6.
Federal officials this month warned 21 Medicare Advantage insurers with high rates of errors in their online network directories that they could face heavy fines or have to stop enrolling people if the problems are not fixed by Feb. 6.
Among the plans that were cited are Blue Cross Blue Shield of Michigan, Highmark of Pennsylvania, SCAN Health Plan of California as well as some regional plans owned by national carriers such as UnitedHealthcare and Humana.
The action follows the government's first in-depth review of the accuracy of Medicare Advantage provider directories, which consumers and advocates have complained about for years. More than 17 million Americans, or nearly a third of Medicare beneficiaries, get coverage through private Medicare Advantage plans, which are an alternative to traditional Medicare.
The Centers for Medicare & Medicaid Services in October reported some of the results of the audit, but they had not released names or statistics from the individual plans.
"Because Medicare Advantage members rely on provider directories to locate an in-network provider, these inaccuracies pose a significant access-to-care barrier," Medicare officials wrote in a report released last week outlining the problems.
Unlike traditional Medicare, the private Medicare plans typically restrict beneficiaries to a network of doctors and hospitals.
Piedmont Community Health Plan, a small Medicare plan with about 5,200 members in southwest Virginia, had the highest rate of inaccuracies among the 54 insurers examined. Officials found errors in the listings of 87 of 108 doctors checked in Piedmont's directory, according to the report. Most of the errors involved providing the wrong locations for doctors and doctors who should not have been listed.
Piedmont officials did not return calls for comment.
Piedmont and two other plans with the highest error rates — a WellCare plan in Illinois and Emblem Health's ConnectiCare subsidiary — were required by Medicare to submit specific business plans detailing how they intend to address the issue.
The individual plans receiving warning letters cover more than 1.4 million beneficiaries. Most operate in numerous states, although CMS generally limited its review to a specific state or geographic area.
The federal review focused on reviewing primary care doctors, cardiologists, ophthalmologists and oncologists. It involved individual calls to check on the listings for 108 doctors in each health plan. "We encountered several instances where a call to a provider's office resulted in determining that the provider had been retired or deceased for a long period of time, sometimes years," the report said.
The CMS report found almost half of the 5,832 doctors listed had incorrect information, including wrong addresses and wrong phone numbers. Most health plans had inaccurate information for between 30 to 60 percent of their providers' offices, the report said. The report blamed the insurers for failing to do enough to keep their directories accurate. Members rely on the directories in both deciding whether to join a plan and then in searching for doctors to treat them.
"We saw a general lack of internal audit and testing of directory accuracy among many" Medicare Advantage organizations, the report said.
CMS' survey found the most error-prone listings involved doctors with multiple offices that did not serve health plan members at each location.
The health plans were sent the warning letters Jan. 6 and given 30 days to fix the mistakes or face possible fines or sanctions, which could include suspending marketing and enrollment. CMS officials said the report was not issued before the annual open enrollment period — which ended Dec. 7 — because of the need to allow the health plans to review the findings before the report was made public.
Medicare Advantage members have until Feb. 14 to disenroll and join traditional Medicare but after that they are locked into their plan for the rest of the year. Seniors may be able to request permission to change plans on a case-by-case basis by calling 800-MEDICARE.
Another 32 companies with less serious mistakes also received letters saying their directories did not comply with a rule that took effect last year requiring plans to contact doctors and other providers every three months and to update their online directories in "real time."
ConnectiCare spokeswoman Kimberly Kann acknowledged the difficulties. "Keeping these directories up-to-date is a two-way street and we are working with doctors and other medical professionals to continue providing quality service," she said.
WellCare spokeswoman Crystal Warwell Walker said the Tampa, Fla.-based company took the survey results seriously. "We modified our data gathering techniques and online reporting options to ensure that when more than one address is listed for a provider, that provider is practicing at that location on a routine basis and access to care is not compromised," she said.
CMS is continuing its investigation of provider directories this year and expects to examine all 300 companies by end of 2018.
If you think that because you get health insurance through your job at a big company, you won't be affected if Republicans overhaul Obamacare, think again. Several of the law's provisions apply to plans offered by large employers too (with some exceptions for plans that were in place before the law passed in March 2010).
It's not yet clear how President-elect Donald Trump and the congressional Republicans plan to revamp the federal health law. They have not agreed on a plan, and they do not have enough votes in the Senate to fully repeal the current statute. So they are planning to use a budgeting rule to disassemble part of the law, and that will limit what they can change. But they also may seek revisions in important regulations and guidance that have determined how the law is implemented.
Nonetheless, as the tensions grow in Washington over the future of the health law, it is important to understand some of its effects on large-group plans.
No Copays For Preventive Services
The health insurance offered by big companies is typically pretty comprehensive, the better to attract and keep good employees. But Obamacare broadened some coverage requirements. Under the law, insurers and employers have to cover many preventive services without charging people anything for them. The services that are required with no out-of-pocket payments include dozens of screenings and tests, including mammograms and colonoscopies, that are recommended by the U.S. Preventive Services Task Force; routine immunizations endorsed by the federal Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices; and a range of services that are recommended specifically for children and for women by the federal Health Resources and Services Administration.
The change that affects the most people on an ongoing basis is likely the requirement that plans cover without cost sharing all methods of contraception approved by the Food and Drug Administration. (There are limited exceptions for religious employers.)
"In terms of sustained costs, birth control is probably the biggest," said Caroline Pearson, a senior vice president at Avalere Health.
No Annual Or Lifetime Limits On Coverage
Even the most generous plans often had lifetime maximum coverage limits of a few million dollars before the health law passed, and some plans also imposed annual coverage limits. The health law eliminated those dollar coverage limits.
Annual Cap On Out-Of-Pocket Payments For Covered Services
The health law set limits on how much people can be required to pay in deductibles, copayments or coinsurance every year for covered care they receive from providers in their network. In 2017, the limit is $7,150 for individuals and $14,300 for families.
"Many employers often had an out-of-pocket limit anyway, but this guarantees protection for people with high needs," said JoAnn Volk, a research professor at Georgetown University's Center on Health Insurance Reforms, who has written on this issue.
Adult Kids' Coverage Expanded
The law allowed workers to keep their children on their plans until they reach age 26, even if they're married, financially independent and live in another state. Republicans have said they may keep this popular provision in place if they dismantle the law.
Guaranteed External Appeal Rights
Consumers who disagree with a health plan's decision to deny benefits or payment for services can appeal the decision to an independent review panel.
The provision applies to all new health plans, including those offered by self-funded companies that pay their workers' claims directly and who were previously exempt from appeals requirements.
No Waiting Periods To Join A Plan
Employers used to be able to make new employees wait indefinitely before they were eligible for coverage under the company plan. No more. Now the waiting time for coverage can be no more than 90 days.
No Waiting Periods For Coverage Of Pre-Existing Conditions
Prior to the ACA, employers could delay covering workers' chronic and other health conditions for up to a year after they became eligible for a plan. Under the ACA, that's no longer allowed. As a practical matter, though, coverage of pre-existing conditions was rarely an issue in large-group plans, say some health insurance experts.
"It was difficult administratively, and the law of large numbers" meant that one individual's health care costs didn't generally have a noticeable impact on the group, said Karen Pollitz, a senior fellow at the Kaiser Family Foundation. (KHN is an editorially independent program of the foundation.)
Repeal could reopen the door to that prohibited practice, however.
Standardized Plan Descriptions
The law requires all plans to provide a "summary of benefits and coverage" in a standard format that allows consumers to understand their coverage and make apples-to-apples plan comparisons.
Basic Coverage Standards For Large-Group Plans
The health law isn't as prescriptive with large-group plans about the specific benefits that have to be offered. They aren't required to cover the 10 essential health benefits that individual and small-group plans have to include, for example. But the law does require that big companies offer plans that meet a "minimum-value" standard paying at least 60 percent of the cost of covered services, on average. Those that don't could face a fine.
Initially, the online calculator that the federal Department of Health and Human Services provided to help large employers gauge compliance with the minimum value standard gave the green light to plans that didn't cover hospitalization services or more than a few doctor visits a year. Now plans must provide at least that coverage to meet federal standards.
The result: Large employers generally no longer offer so-called "mini-med" policies with very skimpy benefits.
If the health law is repealed, that could change. In some industries with lower-wage workers and smaller profit margins, "they might begin to offer them again, and employees might demand it" to help make the premiums more affordable, said Steve Wojcik, vice president of public policy at the National Business Group on Health, a membership organization representing large employers.
Although the law strengthened coverage for people in large-group plans in several ways, consumer advocates have complained about shortcomings. It aimed to ensure that coverage is affordable by requiring that individuals be responsible for paying no more than 9.69 percent of their household income for individual employer coverage, for example.
If their insurance costs more than that, workers can shop for coverage on the marketplaces set up by the health law and be eligible for premium tax credits — if their income is less than 400 percent of the federal poverty level (about $47,000). But the standard does not take into consideration any additional costs for family coverage.
Consumer advocates also point to the wellness regulations as a problematic area of the law. The health law increased the financial incentives that employers can offer workers for participating in workplace wellness programs to 30 percent of the cost of individual coverage, up from 20 percent.
Such incentives can effectively coerce people into participating and sharing private medical information, critics charge, and unfairly penalize sick people.
"It potentially allows [plans] to discriminate against people with medical conditions, which the ACA is supposed to eliminate," said Linda Blumberg, a senior fellow at the Urban Institute's Health Policy Center.